|
Volume
7 Number 7
July 2019
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer Research
>
Volume
7, Year 2019
>
Number 7, July
|
|
|
CONTENTS
|
▼
|
|
CASE
REPORTS
DIAGNOSIS
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
FOLLOW-UP,
QUALITY OF LIFE
INTEGRATIVE
MEDICINE
PROGNOSIS
TREATMENT
|
|
|
CASE
REPORTS
|
▲
|
.
|
Duncan C, Zamir E, Teh J, Joon DL, Liodakis P.
A blind
spot in urology: Prostate cancer associated retinopathy.
Urol
Case Rep. 2019 Mar 16;24:100872. doi: 10.1016/j.eucr.2019.100872.
eCollection 2019 May.
Source
.
Similar
articles
|
|
|
DIAGNOSIS
|
▲
|
.
|
Afshar-Oromieh A, Vollnberg B, Alberts I, Bähler A,
Sachpekidis C, Dijkstra L, Haupt F, Boxler S, Gross T,
Holland-Letz T, Thalmann G, Heverhagen J, Rominger A, Härmä
K, Maurer MH.
Comparison of PSMA-ligand PET/CT and
multiparametric MRI for the detection of recurrent prostate cancer
in the pelvis.
Eur J Nucl Med Mol Imaging. 2019 Jul 27.
doi: 10.1007/s00259-019-04438-w. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Chen M, Qiu X, Zhang Q, Zhang C, Zhou Y, Zhao X, Fu Y, Wang F, Guo
H.
PSMA uptake on [68Ga]-PSMA-11-PET/CT positively
corrects with prostate cancer aggressiveness.
Q J Nucl
Med Mol Imaging. 2019 Jul 30. doi: 10.23736/S1824-4785.19.03172-8.
[Epub ahead of print] -
Source
,
Similar
articles
|
|
|
.
|
De Bari B, Mazzola R, Aiello D, Aloi D, Gatta R, Corradini S,
Salgarello M, Alongi F.
(68Ga)-PSMA-PET/CT
for the detection of postoperative prostate cancer recurrence:
Possible implications on treatment volumes for radiation therapy.
Cancer Radiother. 2019 Jun;23(3):194-200. doi:
10.1016/j.canrad.2018.09.003. Epub 2019 May 12.
Source
.
Similar
articles
|
|
|
.
|
Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F,
Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B,
Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K,
Fendler WP.
68Ga-PSMA-11 PET Detects
Residual Prostate Cancer after Prostatectomy in a Multicenter
Retrospective Study.
J Urol. 2019 Jun
24:101097JU0000000000000417. doi: 10.1097/JU.0000000000000417.
[Epub ahead of print] -
Source
.
Similar
articles
|
|
|
.
|
Favorito LA.
The multiparametric prostate resonance
imaging with the prostate imaging-reporting and data system
(PI-RADS): the state of art of prostate cancer diagnosis.
Int
Braz J Urol. 2019 May-Jun;45(3):422-423. doi:
10.1590/S1677-5538.IBJU.2019.03.01.
Source
.
Similar
articles
Editorial
referring to: Rozas GQ, et al.,Impact of PI-RADS v2 on indication
of prostate biopsy. Int Braz J Urol. 2019 May-Jun;45(3):486-494.
doi: 10.1590/S1677-5538.IBJU.2018.0564.
Source
.
Similar
articles
|
|
|
.
|
Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY,
Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD,
Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J,
Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J,
Hope TA.
Assessment of 68Ga-PSMA-11 PET Accuracy in
Localizing Recurrent Prostate Cancer: A Prospective Single-Arm
Clinical Trial.
JAMA Oncol. 2019 Mar 28. doi:
10.1001/jamaoncol.2019.0096. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Fletcher SA, von Landenberg N, Cole AP, Gild P, Choueiri TK,
Lipsitz SR, Trinh QD, Kibel AS.
Contemporary national
trends in prostate cancer risk profile at diagnosis.
Prostate
Cancer Prostatic Dis. 2019 Jun 24. doi: 10.1038/s41391-019-0157-y.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Hadaschik B, Ost P.
Re: Assessment of 68Ga-PSMA-11
PET Accuracy in Localizing Recurrent Prostate Cancer: A
Prospective Single-Arm Clinical Trial.
Eur Urol. 2019
May 23. pii: S0302-2838(19)30420-8. doi:
10.1016/j.eururo.2019.05.016. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Kalapara AA, Nzenza T, Pan HY, Ballok Z, Ramdave S, O'Sullivan R,
Ryan A, Cherk M, Hofman MS, Konety BR, Lawrentschuk N, Bolton D,
Murphy DG, Grummet JP, Frydenberg M.
Detection and
localisation of primary prostate cancer using 68
Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy
specimens.
BJU Int. 2019 Jul 1. doi: 10.1111/bju.14858.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Koschel SG, Wong LM, Heinze S, Zargar H.
Re: Detection of
Individual Prostate Cancer Foci via Multiparametric Magnetic
Resonance Imaging.
Eur Urol. 2019 May 27. pii:
S0302-2838(19)30424-5. doi: 10.1016/j.eururo.2019.05.020. [Epub
ahead of print]
Source
.
Similar
articles
Comment
on: Johnson DC et al, Detection
of Individual Prostate Cancer Foci via Multiparametric Magnetic
Resonance Imaging.
Eur
Urol. 2018 Nov 30. pii: S0302-2838(18)30930-8. doi:
10.1016/j.eururo.2018.11.031. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Panebianco V, Valerio MC, Giuliani A, Pecoraro M, Ceravolo I,
Barchetti G, Catalano C, Padhani AR.
Clinical Utility of
Multiparametric Magnetic Resonance Imaging as the First-line Tool
for Men with High Clinical Suspicion of Prostate Cancer.
Eur
Urol Oncol. 2018 Aug;1(3):208-214. doi: 10.1016/j.euo.2018.03.008.
Epub 2018 May 15.
Source
.
Similar
articles
|
|
|
.
|
Rauscher I, Krönke M, König M, Gafita A, Maurer T, Horn
T, Schiller K, Weber WA, Eiber M.
Matched-pair comparison
of 68Ga-PSMA-11 and 18F-PSMA-1007
PET/CT: frequency of pitfalls and detection efficacy in
biochemical recurrence after radical prostatectomy.
J
Nucl Med. 2019 Jun 28. pii: jnumed.119.229187. doi:
10.2967/jnumed.119.229187. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Rowe SP, Campbell SP, Mana-Ay M, Szabo Z, Allaf ME, Pienta KJ,
Pomper MG, Ross AE, Gorin MA.
Prospective Evaluation of
PSMA-Targeted 18F-DCFPyL PET/CT in Men
with Biochemical Failure after Radical Prostatectomy for Prostate
Cancer.
J Nucl Med. 2019 Jun 14. pii: jnumed.119.226514.
doi: 10.2967/jnumed.119.226514. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Rozas GQ, Saad LS, Melo HJFE,
Gabrielle HAA, Szejnfeld J.
Impact of PI-RADS v2 on
indication of prostate biopsy.
Int Braz J Urol. 2019
May-Jun;45(3):486-494. doi: 10.1590/S1677-5538.IBJU.2018.0564.
Source
.
Similar
articles
|
|
|
.
|
Tonttila PP, Ahtikoski A, Kuisma M, Pääkkö E,
Hirvikoski P, Vaarala MH.
Multiparametric MRI prior to
radical prostatectomy identifies intraductal and cribriform growth
patterns in prostate cancer.
BJU Int. 2019 May 18. doi:
10.1111/bju.14812. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Yaxley JW, Raveenthiran S, Nouhaud FX, Samaratunga H, Yaxley WJ,
Coughlin G, Yaxley AJ, Gianduzzo T, Kua B, McEwan L, Wong D.
Risk
of metastatic disease on 68
gallium-prostate-specific membrane antigen positron emission
tomography/computed tomography scan for primary staging of 1253
men at the diagnosis of prostate cancer.
BJU Int. 2019
May 29. doi: 10.1111/bju.14828. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Viana PCC, Horvat N, do Santos VR Júnior, Lima TC, Romão
DDS, Cerri LMO, de Castro MG, Vargas HA, Miranda JA, Leite CDC,
Cerri GG.
Is possible to rule out clinically significant
prostate cancer using PI-RADS v2 for the assessment of prostate
MRI?
Int Braz J Urol. 2019 May 5;45. doi:
10.1590/S1677-5538.IBJU.2018.0382. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Wang B, Deng H, Cao L.
Re: Hojjat Ahmadzadehfar, Markus
Essler. Prostate-specific Membrane Antigen Imaging: A Game Changer
in Prostate Cancer Diagnosis and Therapy Planning. Eur Urol. In
press. https://doi.org/10.1016/j.eururo.2019.02.028.
Eur
Urol. 2019 May 17. pii: S0302-2838(19)30377-X. doi:
10.1016/j.eururo.2019.05.004. [Epub ahead of print]
Source
.
Similar
articles
Referring
to: Ahmadzadehfar H, Essler M., Prostate-specific Membrane Antigen
Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy
Planning. Eur Urol. 2019 Mar 2. pii: S0302-2838(19)30175-7. doi:
10.1016/j.eururo.2019.02.028. [Epub ahead of print]
Source
.
Similar
articles
In
turn Referring
to: Perera M et al., Gallium-68 Prostate-specific Membrane Antigen
Positron Emission Tomography in Advanced Prostate Cancer-Updated
Diagnostic Utility, Sensitivity, Specificity, and Distribution of
Prostate-specific Membrane Antigen-avid Lesions: A Systematic
Review and Meta-analysis. Eur Urol. 2019 Feb 14. pii:
S0302-2838(19)30095-8. doi: 10.1016/j.eururo.2019.01.049. [Epub
ahead of print].
Source
.
|
|
|
.
|
Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K,
Shinohara K, Carroll PR.
Detection of clinically signifi
cant prostate cancer with PIRADS v2 scores, PSA density, and ADC
values in regions with and without mpMRI visible lesions.
Int
Braz J Urol. 2019 May 5;45. doi:
10.1590/S1677-5538.IBJU.2018.0768. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Zacho H, Jochumsen MR, Langkilde NC, Mortensen JC, Haarmark C,
Hendel HW, Jensen JB, Petersen LJ.
No added value of
18F-sodium fluoride PET/CT for the
detection of bone metastases in patients with newly diagnosed
prostate cancer with normal bone scintigraphy.
J Nucl
Med. 2019 May 30. pii: jnumed.119.229062. doi:
10.2967/jnumed.119.229062. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
EPIDEMIOLOGY,
RISK FACTORS, PREVENTION
|
▲
|
.
|
Abdel-Rahman O.
Prostate Cancer Incidence and Mortality
in Relationship to Family History of Prostate Cancer; Findings
From The PLCO Trial.
Clin Genitourin Cancer. 2019 May
25. pii: S1558-7673(19)30153-3. doi: 10.1016/j.clgc.2019.05.015.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Bonn SE, Holmberg E, Hugosson J, Bälter K.
Is
leisure time sitting associated with mortality rates among men
diagnosed with localized prostate cancer?
Eur J Cancer
Prev. 2019 Jul 22. doi: 10.1097/CEJ.0000000000000523. [Epub ahead
of print]
Source
|
Abstract
|
Similar
articles
|
|
|
.
|
Liss MA, Al-Bayati O, Gelfond J, Goros M, Ullevig S, DiGiovanni J,
Hamilton-Reeves J, O'Keefe D, Bacich D, Weaver B, Leach R,
Thompson IM.
Higher baseline dietary fat and fatty acid
intake is associated with increased risk of incident prostate
cancer in the SABOR study.
Prostate
Cancer Prostatic Dis. 2019 May;22(2):244-251. doi:
10.1038/s41391-018-0105-2. Epub 2018 Nov 1.
Source
.
Similar
articles
|
|
|
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
|
▲
|
.
|
Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I,
Cieslik M, Benelli M, Robinson D, Van Allen EM, Sboner A, Fedrizzi
T, Mosquera JM, Robinson BD, De Sarkar N, Kunju LP, Tomlins S, Wu
YM, Nava Rodrigues D, Loda M, Gopalan A, Reuter VE, Pritchard CC,
Mateo J, Bianchini D, Miranda S, Carreira S, Rescigno P, Filipenko
J, Vinson J, Montgomery RB, Beltran H, Heath EI, Scher HI, Kantoff
PW, Taplin ME, Schultz N, deBono JS, Demichelis F, Nelson PS,
Rubin MA, Chinnaiyan AM, Sawyers CL.
Genomic correlates
of clinical outcome in advanced prostate cancer.
Proc
Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi:
10.1073/pnas.1902651116. Epub 2019 May 6.
Source
.
Similar
articles
|
|
|
.
|
Ma X, Huang J.
Predicting clinical outcome of
therapy-resistant prostate cancer.
Proc Natl Acad Sci U
S A. 2019 Jun 4;116(23):11090-11092. doi: 10.1073/pnas.1906812116.
Epub 2019 May 21.
Source
.
Similar
articles
Comment
on: Abida W, et al, Genomic
correlates of clinical outcome in advanced prostate cancer.
Proc
Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi:
10.1073/pnas.1902651116. Epub 2019 May 6.
Source
.
Similar
articles
|
|
|
.
|
Mauffrey P, Tchitchek N, Barroca V, Bemelmans A, Firlej V, Allory
Y, Roméo PH, Magnon C.
Progenitors from the
central nervous system drive neurogenesis in cancer.
Nature.
2019 May;569(7758):672-678. doi: 10.1038/s41586-019-1219-y. Epub
2019 May 15.
Source
.
Similar
articles
|
|
|
.
|
Zadra G, Loda M.
When fat goes down, prostate cancer is
on the ropes.
Mol Cell Oncol. 2019 Apr 16;6(3):1595308.
doi: 10.1080/23723556.2019.1595308. eCollection 2019.
Source
.
Similar
articles
|
|
|
FOLLOW-UP,
QUALITY OF LIFE
|
▲
|
.
|
Albisinni S, Aoun F, Quackels T, Assenmacher G, Peltier A, van
Velthoven R, Roumeguère T.
Validated Prospective
Assessment of Quality of Life After Robot-Assisted Laparoscopic
Prostatectomy: Beyond Continence and Erections.
Am J
Mens Health. 2019 May-Jun;13(3):1557988319854555. doi:
10.1177/1557988319854555.
Source
.
Similar
articles
|
|
|
.
|
Chung JW, Kim JW, Ha YS, Choi SH, Lee JN, Kim BS, Kim HT, Yoo ES,
Kwon TG, Kim TH.
The Effect of Phosphodiesterase 5
Inhibitor on Biochemical Recurrence Following Radical
Prostatectomy in Patients with Prostate Cancer.
Urol J.
2019 Jun 17;16(3):255-259. doi: 10.22037/uj.v16i3.4263.
Source
.
Similar
articles
|
|
|
.
|
Jayadevappa R, Chhatre S, Malkowicz SB, Parikh RB, Guzzo T, Wein
AJ.
Association Between Androgen Deprivation Therapy Use
and Diagnosis of Dementia in Men With Prostate Cancer.
JAMA
Netw Open. 2019 Jul 3;2(7):e196562. doi:
10.1001/jamanetworkopen.2019.6562.
Source
.
Similar
articles
|
|
|
.
|
Leufgens F, Berneking V, Vögeli TA, Kirschner-Hermanns R,
Eble MJ, Pinkawa M.
Quality of life changes >10 years
following postoperative radiotherapy after radical prostatectomy
for prostate cancer.
Int J Radiat Oncol Biol Phys. 2019
Jun 12. pii: S0360-3016(19)30829-6. doi:
10.1016/j.ijrobp.2019.06.004. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Neumaier MF, Segall CH Júnior, Hisano M, Rocha FET, Arap S,
Arap MA.
Factors affecting urinary continence and sexual
potency recovery after robotic-assisted radical prostatectomy.
Int Braz J Urol. 2019 May 5;45. doi:
10.1590/S1677-5538.IBJU.2018.0704. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
INTEGRATIVE
MEDICINE
|
▲
|
.
|
Joentausta RM, Murtola TJ.
Prostate cancer survival among
statin users after prostatectomy in a Finnish nationwide cohort.
Prostate. 2019;79:583-591.
Prostate. 2019
Sep;79(12):1420-1421. doi: 10.1002/pros.23870. Epub 2019 Jun 24.
Source
.
Similar
articles
Comment
on: Kawada T. RE: Joentausta et al. Prostate cancer survival among
statin users after prostatectomy in a Finnish nationwide cohort.
Prostate. 2019;79:583-591. Prostate. 2019 Sep;79(12):1399. doi:
10.1002/pros.23862. Epub 2019 Jul 23.
Source
.
Similar
articles
In
turn Comment
on: Joentausta RM, et al, Prostate cancer survival among statin
users after prostatectomy in a Finnish nationwide cohort.
Prostate. 2019 May;79(6):583-591. doi: 10.1002/pros.23768. Epub
2019 Jan 16. Source
.
Similar
articles
|
|
|
.
|
Joentausta RM, Rannikko A, Murtola TJ.
Prostate cancer
survival among statin users after prostatectomy in a Finnish
nationwide cohort.
Prostate. 2019 May;79(6):583-591.
doi: 10.1002/pros.23768. Epub 2019 Jan 16.
Source
.
Similar
articles
|
|
|
.
|
Kawada T.
RE: Joentausta et al. Prostate cancer survival
among statin users after prostatectomy in a Finnish nationwide
cohort. Prostate. 2019;79:583-591.
Prostate. 2019
Sep;79(12):1399. doi: 10.1002/pros.23862. Epub 2019 Jul 23.
Source
.
Similar
articles
Comment
on: Joentausta RM, et al, Prostate cancer survival among statin
users after prostatectomy in a Finnish nationwide cohort.
Prostate. 2019 May;79(6):583-591. doi: 10.1002/pros.23768. Epub
2019 Jan 16. Source
.
Similar
articles
|
|
|
.
|
Meijer D, van Moorselaar RJA, Vis AN, Bijnsdorp IV.
Prostate
Cancer Development Is Not Affected by Statin Use in Patients with
Elevated PSA Levels.
Cancers (Basel). 2019 Jul 7;11(7).
pii: E953. doi: 10.3390/cancers11070953.
Source
.
Similar
articles
|
|
|
PROGNOSIS
|
▲
|
.
|
Butler SS, Mahal BA, Lamba N, Mossanen M, Martin NE, Mouw KW,
Nguyen PL, Muralidhar V.
Use and early mortality outcomes
of active surveillance in patients with intermediate-risk prostate
cancer.
Cancer. 2019 May 31. doi: 10.1002/cncr.32202.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Harkin T, Elhage O, Chandra A, Khan N, Kiberu Y, Frydenberg M,
Dasgupta P.
High ductal proportion predicts biochemical
recurrence in prostatic ductal adenocarcinoma.
BJU Int.
2019 May 28. doi: 10.1111/bju.14831. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Hernández Hernández C, Kim Lee D, Sanchez Pérez
M, Escobar SH.
Accuracy of CAPRA-S Score for Predicting
Long-Term Biochemical Progression After Radical Prostatectomy.
Clin Genitourin Cancer. 2019 Jun;17(3):e645-e649. doi:
10.1016/j.clgc.2019.03.014. Epub 2019 Mar 27.
Source
.
Similar
articles
|
|
|
.
|
Hsiang W, Ghabili K, Syed JS, Holder J, Nguyen KA,
Suarez-Sarmiento A, Huber S, Leapman MS, Sprenkle PC.
Outcomes
of Serial Multiparametric Magnetic Resonance Imaging and
Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed
with Active Surveillance.
Eur Urol Focus. 2019 May 27.
pii: S2405-4569(19)30148-8. doi: 10.1016/j.euf.2019.05.011. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Koskas Y, Lannes F, Branger N, Giusiano S, Guibert N, Pignot G,
Walz J, Rossi D, Bastide C.
Extent of positive surgical
margins following radical prostatectomy: impact on biochemical
recurrence with long-term follow-up.
BMC Urol. 2019 May
15;19(1):37. doi: 10.1186/s12894-019-0470-8.
Source
.
Similar
articles
|
|
|
.
|
Martini A, Gandaglia G, Karnes RJ, Zaffuto E, Bianchi M, Gontero
P, Chlosta P, Gratzke C, Graefen M, Tilki D, Cucchiara V, Mirone
V, Kneitz B, Sanchez Salas R, Van Der Poel H, Tombal B, Spahn M,
Joniau TS, Montorsi F, Briganti A; European Multicenter Prostate
Cancer Clinical and Translational Research group (EMPaCT).
Defining the Most Informative Intermediate Clinical
Endpoints for Predicting Overall Survival in Patients Treated with
Radical Prostatectomy for High-risk Prostate Cancer.
Eur
Urol Oncol. 2019 Jul;2(4):456-463. doi: 10.1016/j.euo.2018.12.002.
Epub 2018 Dec 24.
Source
|
Abstract
|
Similar
articles
|
|
|
.
|
Roy S, Morgan SC.
Who Dies From Prostate Cancer? An
Analysis of the Surveillance, Epidemiology and End Results
Database.
Clin Oncol (R Coll Radiol). 2019 May 23. pii:
S0936-6555(19)30191-8. doi: 10.1016/j.clon.2019.04.012. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Sebastian NT, McElroy JP, Martin DD, Sundi D, Diaz DA.
Survival
after radiotherapy vs. radical prostatectomy for unfavorable
intermediate-risk prostate cancer.
Urol Oncol. 2019 May
18. pii: S1078-1439(19)30155-3. doi:
10.1016/j.urolonc.2019.04.022. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Seddik S, Silva M, Dugué AE, Ait Said K, Joly F, Tillou X.
Oncologic Outcomes of Adjuvant versus Salvage
Radiotherapy after Prostatectomy.
Urol Int. 2019 Jun
21:1-7. doi: 10.1159/000501086. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Takeda T, Benfante NE, Assel M, Mulhall JP, Oya M, Touijer KA.
Erectile function recovery at 12 months after
radical prostatectomy for prostate cancer is not associated with
overall survival.
Int J Urol. 2019 Jun 25. doi:
10.1111/iju.14043. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
TREATMENT
|
▲
|
.
|
Bowden P, See AW, Frydenberg M, Haxhimolla H, Costello AJ, Moon D,
Ruljancich P, Grummet J, Crosthwaite A, Pranavan G, Peters JS, So
K, Gwini SM, McKenzie DP, Nolan S, Smyth LML, Everitt C.
Fractionated stereotactic body radiotherapy for up to
five prostate cancer oligometastases: Interim outcomes of a
prospective clinical trial.
Int J Cancer. 2019 Jun 14.
doi: 10.1002/ijc.32509. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Cao HM, Wan Z, Wu Y, Wang HY, Guan C.
Development and
internal validation of a novel model and markers to identify the
candidates for lymph node metastasis in patients with prostate
cancer.
Medicine (Baltimore). 2019 Jul;98(30):e16534.
doi: 10.1097/MD.0000000000016534.
Source
.
Similar
articles
|
|
|
.
|
Cursano MC, Santini D, Iuliani M, Paganelli G, De Giorgi U.
Early
use of abiraterone and radium-223 in metastatic prostate cancer.
Lancet Oncol. 2019 May;20(5):e228. doi:
10.1016/S1470-2045(19)30226-8.
Source
.
Similar
articles
Comment
on: Smith M et al, Addition of radium-223 to abiraterone acetate
and prednisone or prednisolone in patients with
castration-resistant prostate cancer and bone metastases (ERA
223): a randomised, double-blind, placebo-controlled, phase 3
trial. Lancet Oncol. 2019 Mar;20(3):408-419. doi:
10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6.
Source
.
Similar
articles
|
|
|
.
|
Dirix PR, Mercier C, Dirix LY.
Re:
Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can
Local Ablative Radiotherapy Revert Castration-resistant Prostate
Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51.
Eur Urol. 2019 Jun 26. pii: S0302-2838(19)30507-X. doi:
10.1016/j.eururo.2019.06.022. [Epub ahead of print]
Source
.
Similar
articles
Comment
on: Lohaus F, et al., Can Local Ablative Radiotherapy Revert
Castration-resistant Prostate Cancer to an Earlier Stage of
Disease? Eur Urol. 2019 Apr;75(4):548-551. doi:
10.1016/j.eururo.2018.11.050. Epub 2018 Dec 18.
Source
.
Similar
articles
|
|
|
.
|
Gupta A, Pugh TJ, Lam E, Sheridan AD, Nath S.
The Role of
Primary Tumor Treatment and Metastasis-Directed Therapy in
Oligometastatic Prostate Cancer.
Oncology (Williston
Park). 2019 May 14;33(5):187-91.
Source
.
Similar
articles
|
|
|
.
|
Hindié E, Morgat C.
Early use of abiraterone and
radium-223 in metastatic prostate cancer.
Lancet Oncol.
2019 May;20(5):e229. doi: 10.1016/S1470-2045(19)30235-9.
Source
.
Similar
articles
Comment
on: Smith M et al, Addition of radium-223 to abiraterone acetate
and prednisone or prednisolone in patients with
castration-resistant prostate cancer and bone metastases (ERA
223): a randomised, double-blind, placebo-controlled, phase 3
trial. Lancet Oncol. 2019 Mar;20(3):408-419. doi:
10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6.
Source
.
Similar
articles
|
|
|
.
|
Hölscher T, Lohaus F, Wirth M, Troost EGC.
Reply
to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the
Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et
al. Can Local Ablative Radiotherapy Revert Castration-resistant
Prostate Cancer to an Earlier Stage of Disease? Eur Urol
2019;75:548-51.
Eur Urol. 2019 Jun 27. pii:
S0302-2838(19)30506-8. doi: 10.1016/j.eururo.2019.06.021. [Epub
ahead of print]
Source
.
Similar
articles
Comment
on: Dirix PR, et al.,Re: Fabian Lohaus, Klaus Zöphel, Steffen
Löck, et al. Can Local Ablative Radiotherapy Revert
Castration-resistant Prostate Cancer to an Earlier Stage of
Disease? Eur Urol 2019;75:548-51. Eur Urol. 2019 Jun 26. pii:
S0302-2838(19)30507-X. doi: 10.1016/j.eururo.2019.06.022. [Epub
ahead of print]
Source
.
Similar
articles
In
turn Comment
on: Lohaus F, et al., Can Local Ablative Radiotherapy Revert
Castration-resistant Prostate Cancer to an Earlier Stage of
Disease? Eur Urol. 2019 Apr;75(4):548-551. doi:
10.1016/j.eururo.2018.11.050. Epub 2018 Dec 18.
Source
.
Similar
articles
|
|
|
.
|
Lan T, Chen Y, Su Q, Ye J.
Oncological Outcome of
Cytoreductive Radical Prostatectomy in Prostate Cancer Patients
With Bone Oligometastases.
Urology. 2019 Jun 7. pii:
S0090-4295(19)30507-2. doi: 10.1016/j.urology.2019.03.040. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Patel PH, Chaw CL, Tree AC, Sharabiani M, van As NJ.
Stereotactic
body radiotherapy for bone oligometastatic disease in prostate
cancer.
World J Urol. 2019 Jul 25. doi:
10.1007/s00345-019-02873-w. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M,
Matveev V, Piulats JM, Zucca LE, Karyakin O, Kimura G, Matsubara
N, Nahas WC, Nolè F, Rosenbaum E, Heidenreich A, Kakehi Y,
Zhang A, Krissel H, Teufel M, Shen J, Wagner V, Higano C.
Addition of radium-223 to abiraterone acetate and
prednisone or prednisolone in patients with castration-resistant
prostate cancer and bone metastases (ERA 223): a randomised,
double-blind, placebo-controlled, phase 3 trial.
Lancet
Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X.
Epub 2019 Feb 6.
Source
.
Similar
articles
|
|
|
.
|
Song WH, Park JH, Tae BS, Kim SM, Hur M, Seo JH, Ku JH, Kwak C,
Kim HH, Kim K, Jeong CW.
Establishment of Novel
Intraoperative Monitoring and Mapping Method for the Cavernous
Nerve During Robot-assisted Radical Prostatectomy: Results of the
Phase I/II, First-in-human, Feasibility Study.
Eur Urol.
2019 May 15. pii: S0302-2838(19)30359-8. doi:
10.1016/j.eururo.2019.04.042. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Spratt DE.
Combination therapies in prostate cancer:
proceed with caution.
Lancet Oncol. 2019
Mar;20(3):321-323. doi: 10.1016/S1470-2045(18)30929-X. Epub 2019
Feb 6.
Source
.
Similar
articles
Comment
on: Smith M et al, Addition of radium-223 to abiraterone acetate
and prednisone or prednisolone in patients with
castration-resistant prostate cancer and bone metastases (ERA
223): a randomised, double-blind, placebo-controlled, phase 3
trial. Lancet Oncol. 2019 Mar;20(3):408-419. doi:
10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6.
Source
.
Similar
articles
|
|
|
.
|
Tay KJ, Polascik TJ, Howard LE, Salama JK, Schulman AA, Chen Z,
Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK,
Freedland SJ.
Salvage Radiotherapy for Recurrent Prostate
Cancer: Can the Prognostic Grade Group System Inform Treatment
Timing?
Clin Genitourin Cancer. 2019 May 24. pii:
S1558-7673(18)30729-8. doi: 10.1016/j.clgc.2019.05.007. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Thomsen FB, Røder MA, Jakobsen H, Langkilde NC, Borre M,
Jakobsen EB, Frey A, Lund L, Lunden D, Dahl C, Brasso K.
Active
Surveillance Versus Radical Prostatectomy in Favorable-risk
Localized Prostate Cancer.
Clin Genitourin Cancer. 2019
Aug;17(4):e814-e821. doi: 10.1016/j.clgc.2019.05.005. Epub 2019
May 21.
Source
.
Similar
articles
|
|
|
.
|
Verep S, Erdem S, Ozluk Y, Kilicaslan I, Sanli O, Ozcan F.
The
pathological upgrading after radical prostatectomy in low-risk
prostate cancer patients who are eligible for active surveillance:
How safe is it to depend on bioptic pathology?
Prostate.
2019 Jul 3. doi: 10.1002/pros.23873. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
bottom
|
▲
|
***
|
|